Same mechanism as injectable BPC-157 — FAK-paxillin pathway activation, NO synthesis, angiogenesis — delivered via delayed-release oral capsule for gut-targeted action.
For athletes, the primary value of BPC-157 Pro Delayed Release lies in its ability to gut-targeted tissue repair and anti-inflammatory action via convenient oral delivery.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Well tolerated orally. Delayed-release formulation designed to minimize gastric degradation.
Always verify current WADA status with your sport's governing body before use in competition.
Sikiric P, et al. Curr Pharm Des. 2018;24(18):1990-2001.
Start a BPC-157 Pro Delayed Release Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified BPC-157 Pro Delayed Release and comprehensive biomarker monitoring.
Get ProtocolStart Your Performance Protocol for BPC-157 Pro Delayed Release
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised